Abstract
Between 1987 and 1989 the Cancer Research Campaign funded a health education programme for the early detection of cutaneous malignant melanoma in the general population in 6 health districts of England and 1 health board in Scotland (population of 3 million). The intervention was evaluated by studying its effects on annual and cumulative mortality rates for melanoma. Population-based data on mortality from melanoma were collected in the intervention areas, the health regions covering those areas, and 5 other health regions of England from 1981 to 1996. Deaths from melanoma in cases diagnosed after the start of the intervention were used to study cumulative mortality rates. The annual mortality rates for melanoma, 1981 to 1996, showed no significant difference in their trends between the intervention areas, and other areas of England and Wales. After adjustment for pre-intervention rates, there was also no significant reduction in cumulative mortality from melanoma in the intervention areas compared with the non-intervention areas: rate ratio 1.2 (95% Cl 0.9–1.7) in men, 0.9 (95% Cl 0.7–1.3) in females. The lack of a significant reduction in melanoma mortality associated with the intervention raises questions about this approach to early detection and emphasises the need for new strategies. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Berwick M, Begg CB, Fine JA, Roush GC and Barnhill RL (1996) Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst 88: 17–23
Burton RC and Armstrong BK (1994) Recent incidence trends imply a nonmetastasizing form of invasive melanoma. Melanoma Res 4: 107–113
Burton RC, Coates MS, Hersey P, Roberts G, Chetty MP, Chen S, Hayes MH, Howe CG and Armstrong BK (1993) An analysis of a melanoma epidemic. Int J Cancer 55: 765–770
Cohn-Cedermark G, Mansson-Brahme E, Rutqvist LE, Larsson O, Johansson H and Ringborg U (2000) Trends in mortality from malignant melanoma in Sweden, 1970–1996. Cancer 86: 348–355
Cook MG, Clarke TJ, Humphreys S, Fletcher A, McLaren KM, Smith NP, Stevens A, Theaker JM and Melia J (1996) The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel. Histopathol 28: 497–512
Dennis LK (1999) Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Dermatol 135: 275–280
Doherty VR and MacKie RM (1988) Experience of a public education programme on early detection of cutaneous malignant melanoma. BMJ 297: 388–391
Edman RL and Klaus SN (2000) Is routine screening for melanoma a benign practice?. JAMA 284: 883–889
Giles GG, Armstrong BK, Burton RC, Staples MP and Thursfield VJ (1996) Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. BMJ 312: 1121–1125
Healsmith MF, Bourke JF, Osborne JE and Graham Brown RA (1994) An evaluation of the revised seven-point checklist for the early diagnosis of cutaneous malignant melanoma. Br J Dermatol 130: 48–50
Herd RM, Cooper EJ, Hunter JA, Mclaren K, Chetty U, Watson AC and Gollock J (1995) Cutaneous malignant melanoma. Publicity, screening clinics and survival–the Edinburgh experience 1982–90. Br J Dermatol 132: 563–570
Jackson A, Wilkinson C, Ranger M, Pill R and August P (1998) Can primary prevention or selective screening for melanoma be more precisely targeted through general practice? A prospective study to validate a self administered risk score. BMJ 316: 34–39
La Vecchia C, Lucchini F, Negri E and Levi F (1999) Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer 81: 62–66
Lipsker DM, Hedelin G, Heid E, Grosshans EM and Cribier BJ (1999) Striking increase of thin melanomas contrasts with stable incidence of thick melanomas. Arch Dermatol 135: 1451–1456
Little P, Keefe M and White J (1995) Self screening for risk of melanoma: validity of self mole counting by patients in a single general practice. BMJ 310: 912–916
MacKie RM (1989). Malignant Melanoma. A guide to early diagnosis. Edinburgh: ??
MacKie RM and Hole D (1992) Audit of public education campaign to encourage earlier detection of malignant melanoma. BMJ 304: 1012–1015
MacKie RM, Hole D, Hunter JAA, Rankin R, Evans A, Mclaren K, Fallowfield M, Hutcheon A and Morris A (1997) Cutaneous malignant melanoma in Scotland: Incidence, survival and mortality 1979–1994. BMJ 315: 1117–1121
Melia J, Ellman R and Chamberlain J (1994) Investigating changes in awareness about cutaneous malignant melanoma in Britain using the Omnibus Survey. Clin Exp Dermatol 19: 375–379
Melia J, Cooper EJ, Frost T, Graham Brown R, Hunter J, Marsden A, du Vivier A, White J, Whitehead S and Warin AP et al (1995a) Cancer Research Campaign health education programme to promote the early detection of cutaneous malignant melanoma. I. Work-load and referral patterns. Br J Dermatol 132: 405–413
Melia J, Cooper EJ, Frost T, Graham Brown R, Hunter J, Marsden A, du Vivier A, White J, Whitehead S, Warin AP, Wroughton M, Ellman R and Chamberlain J (1995b) Cancer Research Campaign health education programme to promote the early detection of cutaneous malignant melanoma. II. Characteristics and incidence of melanoma. Br J Dermatol 132: 414–421
Melia J, Harland C, Moss S, Eiser JR and Pendry L (2000) Feasibility of targeted early detection for melanoma: a population based screening study. Br J Cancer 82: 1605–1609
Moss SM, Coleman DA, Chamberlain J and Mapp TJ for the United Kingdom Trial of Early Detection of Breast Cancer Group (1999) 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer. Lancet 353: 1909–1914
Office for National Statistics (1998) Mortality Statistics 1997. Series DH2 Ed,
Osborne JE, Bourke JF, Holder J, Colloby P and Graham-Brown RA (1998) The effect of the introduction of a pigmented lesion clinic on the interval between referral by family practitioner and attendance at hospital. Br J Dermatol 138: 418–421
Severi G, Giles GG, Robertson C, Boyle P and Autier P (2000) Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer 82: 1887–1891
Sharp S and Sterne J (1997) sbe 16: Meta-analysis. Stata Technical Bulletin 38: 9–14
Sinclair R (1998) Commentary: Start with the KISS principle. BMJ 316: 38–39
Streetly A and Markowe H (1995) Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health. Int J Epidemiol 24: 897–907
Tabar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grontoft O, Ljunquist U, Lundstrom B, Manson JC, Eklund G and Day NE (1985) Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet i: 829–832
van der Rhee HJ, van der Spek-Keijser LMT, Van Westering R and Coebergh JWW (1999) Increase in and stabilization of incidence and mortality of primary cutaneous malignant melanoma in western Netherlands, 1980–95. Br J Dermatol 140: 463–467
Whitehead SM, Wroughton MA, Elwood JM, Davison J and Stewart M (1989) Effects of a health education campaign for the earlier diagnosis of melanoma. Br J Cancer 60: 421–425
Williams HC, Smith D and Du Vivier AWP (1990) Evaluation of public education campaigns in cutaneous melanoma: The King’s College Hospital experience. Br J Dermatol 123: 85–92
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Melia, J., Moss, S., Coleman, D. et al. The relation between mortality from malignant melanoma and early detection in the Cancer Research Campaign Mole Watcher Study. Br J Cancer 85, 803–807 (2001). https://doi.org/10.1054/bjoc.2001.2012
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2012
Keywords
This article is cited by
-
Conflicts and Contradictions in Current Skin Cancer Screening Guidelines
Current Dermatology Reports (2017)